Maryland HB 631: Public Health - Essential Off-Patent or Generic Drugs - Price Gouging - Prohibition

Status: Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 818 (as of 2017-05-27)

State: Maryland · Session: 2017 · Bill: HB 631

Subjects: Public Health, Attorney General, Circuit Courts, Civil Actions, Consumer Protection, Drugs, Federal Government, Health, Industry and Technology, Medical Assistance, Notices, Penalties and Sentences, Pharmacists and Pharmacies, Prices, Privacy, Records, Time

Sponsors: The Speaker (By Request - Office of the Attorney General) and Bromwell, A. Miller, A. Washington, Anderson, Angel, Atterbeary, Aumann, B. Barnes, Barkley, Barron, Barve, Beidle, Brooks, C. Howard, C. Wilson, Carey, Carr, Chang, Clippinger, Conaway, Cullison, D. Barnes, Davis, Dumais, Ebersole

View Maryland HB 631 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.